Ribavirin and interferon∝-2b combination therapy for 48 weeks in patients with chronic hepatitis C who either failed (non-responder) or relapsed (relapsers) from previous interferon monotherapy.

被引：0
|
作者：
Tsai, NC
Coste, A
Shimoda, N
Yee, H
Jao, R
Wong, L
Buto, S
Shimoda, S
机构：
[1] Univ Hawaii, Honolulu, HI 96822 USA
[2] St Francis Med Ctr, Honolulu, HI USA
[3] Univ Hawaii, Honolulu, HI 96822 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
429
引用
收藏
页码：268A / 268A
页数：1
相关论文
共 50 条
  • [1] Interferon alfa 2B and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon monotherapy.
    Hajjar, B
    Galica, M
    Weisz, K
    Salen, G
    Dieterich, DT
    HEPATOLOGY, 1999, 30 (04) : 624A - 624A
  • [2] Response to interferon alpha 2B plus ribavirin in hepatitis C infected patients who failed interferon alpha 2B monotherapy.
    King, JW
    Favrot, DR
    Shakhashiro, A
    Gholson, CF
    Balart, LA
    Achord, J
    Kirkikis, JA
    Lyles, WE
    Hollier, JD
    Srinivas, D
    HEPATOLOGY, 1998, 28 (04) : 708A - 708A
  • [3] Retreatment with ribavirin and interferon alpha 2b of relapsers and non responders to monotherapy.
    Munoz, S
    Suvannasankha, A
    DiGregorio, K
    Stein, L
    Gross, F
    Peikin, S
    Perez, O
    Benson, G
    Mushnick, A
    DeAngelo, C
    Golbfarb, J
    Rothstein, K
    Kern, N
    Fleischer, D
    GASTROENTEROLOGY, 1998, 114 (04) : A1307 - A1307
  • [4] Long term interferon and ribavirin combination therapy in chronic hepatitis C patients unresponsive to interferon monotherapy.
    Anderson, FH
    Rock, NR
    Sherlock, C
    HEPATOLOGY, 1998, 28 (04) : 716A - 716A
  • [5] Combined interferon alfa-2b and ribavirin therapy of chronic hepatitis C patients who were non-responsive to or relapsed after interferon monotherapy.
    Labrecque, DR
    Schmidt, WN
    Phillips, MJP
    Schrock, D
    Ippolito, LA
    Juhl, R
    Voigt, MD
    Brashear, D
    Martin, A
    Adler, E
    Chene, B
    Tamburro, C
    HEPATOLOGY, 2001, 34 (04) : 329A - 329A
  • [6] Treatment of chronic hepatitis C in patients who failed interferon monotherapy: Effects of higher doses of interferon and ribavirin combination therapy
    Shiffman, ML
    Hofmann, CM
    Gabbay, J
    Luketic, VA
    Sterling, RK
    Sanyal, AJ
    Contos, MJ
    Ryan, MJ
    Yoshida, C
    Rustgi, V
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10): : 2928 - 2935
  • [7] Re-treatment virologic response in chronic hepatitis C virologic non-responders (NR) and responder-relapsers (NR) to interferon (IFN) monotherapy:: IFN α-2b induction followed by combination ribavirin/interferon α-2b vs combination ribavirin/interferon α-2b (780 MIU/52 weeks rebetron therapy).
    Pimstone, NR
    Canio, JB
    Chiang, MH
    Kokosinski, J
    Powell, JS
    Saicheur, T
    Sheykhzadeh, PI
    Yu, AS
    GASTROENTEROLOGY, 2001, 120 (05) : A568 - A568
  • [8] Retreatment for 24 vs 48 weeks with interferon-α2b plus ribavirin of chronic hepatitis C patients who relapsed or did not respond to interferon alone
    Enríquez, J
    Gallego, A
    Torras, X
    Pérez-Olmeda, T
    Diago, M
    Soriano, V
    Luján, MS
    García-Samaniego, J
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (06) : 403 - 408
  • [9] Early prediction of sustained viral responder and non-responder during interferon and ribavirin combination therapy in chronic hepatitis C
    Nakamura, H
    HEPATOLOGY RESEARCH, 2005, 33 (04) : 269 - 271
  • [10] EFFECTS OF CASCADE FILTRATION IN COMBINATION WITH INTERFERON AND RIBAVIRIN IN THE TREATMENT OF NON-RESPONDER CHRONIC HEPATITIS C PATIENTS
    Ramunni, A.
    Brescia, P.
    Burzo, M.
    Verno, L.
    Rendina, M.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (07): : 436 - 436
12345